Mex$0.37
99.00%
Mexican, Sep 18, 02:00 pm CST. Closed.
Why the stock moved Why the stock moved Beta
ISIN
MX01GE0E0004
Symbol
GENTERA

Genterab De Cv Target price 2026 - Analyst rating & recommendation

Genterab De Cv Classifications & Recommendation

Buy
70%
Hold
25%
Sell
5%

Genterab De Cv Price Target

Target Price Mex$53.04
Price Mex$37.08
Potential
Number of Estimates 16
16 Analysts have issued a price target Genterab De Cv 2027 . The average Genterab De Cv target price is Mex$53.04. This is higher than the current stock price. The highest price target is
Mex$70.35 89.72%
register free of charge
, the lowest is
Mex$45.45 22.57%
register free of charge
.
A rating was issued by 20 analysts: 14 Analysts recommend Genterab De Cv to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genterab De Cv stock has an average upside potential 2027 of . Most analysts recommend the Genterab De Cv stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion Mex$ 48.27 54.60
24.10% 13.12%
Net Margin 17.02% 17.23%
10.25% 1.23%

14 Analysts have issued a sales forecast Genterab De Cv 2026 . The average Genterab De Cv sales estimate is

Mex$54.6b
unlock
. This is
6.21% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
Mex$92.8b 80.46%
unlock
, the lowest is
Mex$43.9b 14.57%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 Mex$48.3b 24.10%
2026
Mex$54.6b 13.12%
unlock
2027
Mex$55.9b 2.33%
unlock
2028
Mex$60.8b 8.76%
unlock

15 Genterab De Cv Analysts have issued a net profit forecast 2026. The average Genterab De Cv net profit estimate is

Mex$9.4b
unlock
. This is
7.90% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
Mex$10.0b 14.70%
unlock
, the lowest is
Mex$8.5b 2.00%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 Mex$8.2b 36.82%
2026
Mex$9.4b 14.49%
unlock
2027
Mex$10.4b 10.23%
unlock
2028
Mex$11.5b 11.26%
unlock

Net Margin

2025 17.02% 10.25%
2026
17.23% 1.23%
unlock
2027
18.56% 7.72%
unlock
2028
18.98% 2.26%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share Mex$ 5.20 5.96
36.84% 14.62%
P/E 6.23
EV/Sales 1.93

15 Analysts have issued a Genterab De Cv forecast for earnings per share. The average Genterab De Cv EPS is

Mex$5.96
unlock
. This is
7.97% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
Mex$6.33 14.67%
unlock
, the lowest is
Mex$5.41 1.99%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 Mex$5.20 36.84%
2026
Mex$5.96 14.62%
unlock
2027
Mex$6.57 10.23%
unlock
2028
Mex$7.30 11.11%
unlock

P/E ratio

Current 6.72 28.53%
2026
6.23 7.26%
unlock
2027
5.65 9.31%
unlock
2028
5.08 10.09%
unlock

Based on analysts' sales estimates for 2026, the Genterab De Cv stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.05 22.93%
2026
1.93 5.75%
unlock
2027
1.89 2.27%
unlock
2028
1.74 8.06%
unlock

P/S ratio

Current 1.14 30.53%
2026
1.07 5.86%
unlock
2027
1.04 2.27%
unlock
2028
0.96 8.05%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today